COLD PLASMA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Cold Plasma Market Size and Forecast – 2025 to 2032

The Global Cold Plasma Market is estimated to be valued at USD 2.18 Bn in 2025 and is expected to reach USD 4.97 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032. This rapid growth reflects increasing adoption across the healthcare, food processing, and environmental sectors, driven by the technology’s efficacy in sterilization, surface modification, and pollution control applications. The expanding investment in research and development further propels market expansion.

Key Takeaways of the Global Cold Plasma Market

• In the global cold plasma market, the atmospheric pressure cold plasma segment is expected to lead with a 70. 1% share in 2025, driven by its clear advantages over low-pressure systems.
• Wound healing and tissue regeneration account for the largest share among applications at an estimated share of 31. 3%,
• By end user, hospitals and clinics represent the leading end-user group with an estimated share of 25. 5% in 2025.
• North America is expected to lead the market, holding a share of 36. 3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 24.2% in 2025.

Market Overview

A significant market trend in cold plasma technology is its increasing integration with sustainable and eco-friendly industrial practices. Industries are progressively leveraging cold plasma for energy-efficient sterilization and treatment processes, reducing chemical usage and environmental impact. Additionally, innovations in device portability and versatility are enhancing end-user accessibility across medical, agricultural, and environmental monitoring fields. Growing governmental support for green technologies and heightened awareness about plasma’s non-thermal advantages continue to fuel market adoption and innovation momentum.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Cold Plasma Market Insights, By Regime – Atmospheric Pressure Cold Plasma Leads Due to Versatility and Cost-Effectiveness

In the global cold plasma market, the atmospheric pressure cold plasma segment is expected to dominate due to its distinct advantages over low-pressure alternatives with 70.1% in 2025, particularly in terms of operational flexibility and application scope. Unlike low-pressure cold plasma systems that require vacuum chambers and complex infrastructure, It operates at ambient conditions, which significantly reduces setup costs and enhances ease of integration into existing processes. This accessibility has propelled its widespread adoption across diverse industries.

One of the critical growth drivers for the atmospheric pressure cold plasma segment is its versatility in treating large, irregular, or heat-sensitive surfaces without damaging the material or interrupting workflow. This makes it highly suitable for industrial surface modifications, sterilization, and biomedical applications where delicate substrates are involved. Additionally, APCP’s compatibility with in-line processing and continuous manufacturing enhances productivity and efficiency, appealing to sectors that prioritize scalable and cost-effective solutions.

Cold Plasma Market Insights, By Application – Wound healing and tissue regeneration stand out as the foremost application segment due to their critical role in addressing chronic, hard-to-heal wound

Wound healing and tissue regeneration stand out as the largest application segment within the cold plasma market with an estimated share of 31.3% in 2025, driven primarily by the urgent need for innovative, non-invasive medical technologies. Cold plasma presents a revolutionary approach to accelerating soft tissue repair, reducing microbial load, and promoting cell proliferation without the adverse effects linked to traditional treatments. Its antimicrobial properties effectively combat multi-drug-resistant bacteria, which is a significant concern in chronic wounds like diabetic foot ulcers, pressure sores, and burns.

The rising prevalence of chronic wounds worldwide due to aging populations and increasing incidences of diabetes and obesity amplifies the demand for advanced therapeutic options. Cold plasma’s ability to enhance angiogenesis and modulate inflammation helps speed up healing times, lower infection rates, and improve overall patient outcomes. This biological impact positions cold plasma as an attractive adjunct or alternative to conventional wound care therapies.

Cold Plasma Market Insights, By End User – Hospitals and Clinics Driving Demand as Primary End Users Owing to Their Expanding Role in Advanced Wound Care, Infection Control, and Surgical Applications

Hospitals and clinics are projected to emerge as the most significant end-user segment in the cold plasma market with 25.5% in 2025, underpinned by their critical role in delivering complex healthcare services. These facilities demand reliable, effective, and scalable plasma solutions that can be seamlessly incorporated into routine medical and surgical workflows. The intensive need for infection control, wound care, and sterilization within hospital settings underscores the growing reliance on cold plasma technologies.

One primary driver within hospitals is the escalating emphasis on preventing healthcare-associated infections (HAIs), which pose substantial risks to patient safety and impose high financial burdens. Cold plasma offers an efficient alternative to traditional sterilization techniques, enabling rapid decontamination of surgical instruments, hospital surfaces, and air without leaving toxic residues. This capability supports infection prevention protocols crucial to hospital accreditation and quality care standards.

Regional Insights

To learn more about this report, Download Free Sample

North America Cold Plasma Market Analysis and Trends

In North America, the dominance in the global cold plasma market with an estimated share of 36.3% in 2025 is driven by a well-established market ecosystem characterized by advanced research infrastructure, strong government support, and a robust industrial base. The region benefits from significant investments in healthcare, electronics, and environmental sectors where cold plasma technology finds widespread applications such as sterilization, surface modification, and air purification.

Government policies fostering innovation and stringent regulatory standards for hygiene and sterilization further propel market adoption. The presence of leading companies such as PlasmaTech Inc., Advanced Plasma Solutions, and Cold Plasma Innovations enhances technological advancements and product offerings. North America's strong trade networks and well-developed supply chains ensure efficient distribution and integration of cold plasma technologies across multiple industries, reinforcing its leading position.

Asia Pacific Cold Plasma Market Analysis and Trends

Asia Pacific is expected to exhibit the fastest growth in the global cold plasma market, accounting for 24.2% in 2025 due to rapid industrialization, expanding healthcare infrastructure, and growing environmental awareness. Emerging economies like China, India, Japan, South Korea, and Australia are increasingly adopting cold plasma technology to address challenges related to sterilization, water treatment, and electronics manufacturing. Government initiatives promoting healthcare modernization and environmental sustainability, coupled with growing investments in R&D, are significant growth catalysts.

In September 2023, Indian Institute of Technology Jodhpur, a leading research institution in India, announced that its researchers had developed the Novel Cold-Plasma Detergent in Environment (CODE) device to improve indoor air quality by deactivating over 99.99% of harmful pathogens. The device, which combines non-equilibrium cold plasma with nanotechnology, has been tested extensively for office-sized rooms and is easily scalable for larger spaces while meeting OSHA indoor air quality standards.

Global Cold Plasma Market Outlook for Key Countries

U.S. Cold Plasma Market Trends

The U.S. continues to lead the cold plasma market with its cutting-edge research facilities and high adoption rates across various end-use industries such as healthcare, food processing, and electronics. Companies like Advanced Plasma Solutions and PlasmaTech Inc. have pioneered innovative cold plasma applications, contributing significantly to market expansion. Supportive regulatory frameworks and active collaboration between academia and industries enable rapid commercialization of new technologies, reinforcing the country’s leadership in the market.

In February 2025, Royal Biologics, a U.S.-based company specializing in advanced wound care through its division Royal Wound-X, announced a strategic partnership with Coldplasmatech GmbH, a German innovator in medical cold plasma technology, to transform the treatment for complex and chronic wounds. Coldplasmatech’s Cold Atmospheric Plasma system, which includes the CPT cube control device and CPT patch applicator, has shown strong potential against multi-drug-resistant infections and is already registered as a class IIb medical device in the EU.

China Cold Plasma Market Trends

China's cold plasma market is expanding rapidly, fueled by large-scale industrial growth and rising demand for sterilization and environmental remediation solutions. The government’s focus on modernizing healthcare infrastructure and implementing stringent environmental regulations encourages the adoption of advanced plasma technologies. Key players such as Shenzhen Zephyr Plasma Technologies and local subsidiaries of global firms are instrumental in driving product development and market outreach, aiding China’s rapid rise as a prominent player in the global market.

In April 2025, CU Medicine the Faculty of Medicine at The Chinese University of Hong Kong together with the University of Oxford, Fudan University, and the London School of Hygiene and Tropical Medicine published the world’s first large-scale study on the impact of temperature on nearly 3,000 plasma proteins in Chinese adults. Analyzing data from the China Kadoorie Biobank, the researchers found that 949 proteins responded significantly to temperature changes, with over 80% linked to systolic blood pressure and ischemic heart disease risk

Germany Cold Plasma Market Trends

Germany’s cold plasma market is marked by strong industry-academia collaboration and a focus on precision engineering, making it a hub for innovative cold plasma applications in automotive and electronics sectors. Companies such as PlasmaCom GmbH and Fraunhofer Institute contribute extensively through R&D and industrial-grade applications. Environmental policies emphasizing sustainable manufacturing practices also support market growth by increasing the demand for cold plasma solutions in surface treatment and sterilization processes within the region.

In May 2025, Terraplasma, a German company founded by physicist and biophysicist Mrs. Julia Zimmermann, introduced PHLAS, a new cold plasma skincare device designed to treat acne and improve skin health. Developed from Zimmermann’s research at the Max Planck Institute and advanced through her ventures terraplasma, terraplasma medical, and hyped about science, the device uses surface micro-discharge technology to safely generate cold plasma that mimics the body’s immune response.

India Cold Plasma Market Trends

India’s cold plasma market is rapidly evolving due to growing awareness about cold plasma applications in healthcare and agriculture, coupled with increasing industrial automation. The government’s push for “Make in India” and digital health initiatives create a conducive environment for market expansion. Companies such as PlasmaTech India and emerging start-ups focus on affordable and scalable cold plasma solutions tailored for local needs, boosting domestic market growth alongside rising imports of advanced plasma technologies.

In December 2023, PlasmaGen Biosciences a Bengaluru-based biopharmaceutical company specializing in blood plasma-derived pharmaceutical products, raised funds in equity financing from Artian Investments, Mr. Ashish Kacholia, pharmaceutical entrepreneurs, Mr. Anurag Bagaria and Mr. Dushyant Patel, along with continued support from existing investors Eight Roads Ventures and F-Prime Capital. Founded in 2010, the company has now raised a total of USD 48 million and will use the fresh funding to expand internationally, develop new products, and strengthen working capital.

End User Feedback and Unmet Needs in the Cold Plasma Market

• Healthcare providers who have adopted cold plasma technologies consistently highlight their strong performance in infection control and wound management. Clinicians working in advanced wound care units have shared positive experiences with how cold plasma accelerates healing in chronic ulcers and surgical wounds, often reducing dependency on prolonged antibiotic use. In some cases, hospitals reported that patients with diabetic foot ulcers responded favorably, with faster tissue regeneration and reduced infection risk compared to conventional treatments. This has built confidence among practitioners who view cold plasma as a reliable adjunct therapy that not only improves clinical outcomes but also supports broader antimicrobial stewardship goals in healthcare systems.
• At the same time, recurring concerns emerge from end users around integration, affordability, and operational complexities. Smaller clinics and regional hospitals often struggle with the high upfront investment costs and limited availability of cold plasma devices tailored for lower patient volumes. Some practitioners also point to challenges in staff training and device handling, noting that the technology requires more intuitive interfaces and standardized protocols to ease adoption. Unmet needs remain in the form of more affordable, portable, and application-specific devices, particularly for resource-constrained healthcare settings. Addressing these gaps through cost innovation, better customization for different medical specialties, and stronger after-sales support would not only expand access but also create a path for wider market penetration, strengthening long-term adoption and trust in cold plasma solutions.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In July 2025, Venture Medical LLC, a U.S.-based leader in advanced wound care solutions, announced a strategic investment in Plasmacure BV, a Dutch MedTech company recognized for its award-winning cold plasma wound healing system, PLASOMA. Together with Coöperatie VGZ, Noaber, Stichting Triade, and existing investors EIC Fund and OostNL, Venture Medical will contribute more than USD 10 million in funding. The investment is aimed at supporting Plasmacure’s efforts to secure U.S. regulatory approval, develop reimbursement pathways, and accelerate market expansion.
• In November 2024, Viromed Medical AG, a German healthcare company specializing in innovative medical technologies, advanced its research on using cold plasma as a “digital antibiotic” to prevent ventilator-associated pneumonia. The study is led by Prof. Dr. Hortense Slevogt through BREATH the Biomedical Research in End-stage and Obstructive Lung Disease network at Hannover Medical School, part of the German Center for Lung Research.
• In April 2024, neoplas med GmbH, a German-based leader in cold plasma jet medical technology, announced that its Plasmajet kINPen MED has received the European Medical Device Regulation (MDR) certificate, underscoring the company’s strong commitment to safety and quality in healthcare. Recognized as the most well-documented cold plasma system worldwide with over 300 scientific publications and proven clinical efficacy in treating wounds and skin diseases, the MDR certification places neoplas med among the top 10% of MedTech firms in Europe to achieve this milestone, further strengthening its pioneering role in advancing medical cold plasma therapy.
• In February 2024, Adtec Healthcare visited Taiwan to advance its SteriPlas expansion project, focusing on enhancing cold plasma technology for sterilization applications. This initiative aims to strengthen Adtec's presence in the Asian cold plasma market, addressing the growing demand for innovative healthcare solutions. The expansion reflects the company's commitment to improving healthcare standards through advanced sterilization techniques and technology partnerships.

Top Strategies Followed by Global Cold Plasma Market Players

• Established market leaders primarily focus on heavy investments in research and development (R&D) to drive innovation in high-performance cold plasma products. By enhancing the efficacy, safety, and versatility of their offerings, these players aim to meet the sophisticated demands of various end-use sectors, including healthcare, electronics, and environmental sterilization. In addition to technological advancements, they actively pursue strategic partnerships and collaborations with major industry stakeholders and original equipment manufacturers (OEMs).
  • For example, Apyx Medical Corporation in the U.S. has built a strong presence with its plasma-based surgical and cosmetic devices, targeting minimally invasive procedures and dermatological treatments. Similarly, Adtec Healthcare in the U.K. has pioneered cold plasma therapy for wound care, with its devices being used in hospitals to treat infected and chronic wounds while supported by numerous clinical trials. Both companies emphasize regulatory approvals, hospital partnerships, and continuous R&D to expand their healthcare portfolios.

• Mid-level players in the cold plasma market position themselves as providers of cost-effective solutions that maintain an optimal balance between quality and affordability. Recognizing the price sensitivity of certain customer segments, particularly in developing regions, these companies tailor their offerings to meet budget constraints without compromising on essential performance attributes.
  • For example, mid-level players in the cold plasma market are steadily gaining visibility by offering affordable and specialized solutions for clinical use. Adtec Healthcare Limited in the U.K. has built a strong reputation with its plasma devices for chronic wound care, widely adopted in hospitals across Europe. In the U.S., US Medical Innovations is developing plasma-based therapies for oncology and surgical applications, addressing the urgent need for safer cancer treatments. CINOGY GmbH from Germany contributes with its PlasmaDerm system, designed for dermatology and wound healing, while Plasma Concepts in India focuses on delivering cost-sensitive cold plasma solutions to emerging markets.

• Small-scale players in the global cold plasma market differentiate themselves by targeting niche segments through specialized features or innovative product designs aimed at specific industry needs. These companies often adopt emerging and cutting-edge technologies to stay at the forefront of market trends, fostering agility and rapid iteration in their offerings. Their ability to experiment with novel approaches positions them as trendsetters in areas such as portable cold plasma devices or tailored sterilization systems for unique applications.
  • For example, in July 2020, Plasmacure BV a Netherlands-based MedTech company specializing in cold plasma wound healing launched its EU-funded PLASOMA project under the Horizon 2020 program to develop innovative solutions for chronic wounds

Market Report Scope

Cold Plasma Market Report Coverage

Cold Plasma Market Dynamics

To learn more about this report, Download Free Sample

Cold Plasma Market Driver - Expansion in Medical Sterilization Applications

The growing adoption of cold plasma technology in medical sterilization is a significant driver propelling the global cold plasma market forward. Cold plasma offers an advanced and efficient sterilization solution that effectively eradicates a wide range of pathogens, including bacteria, viruses, and fungi, without damaging sensitive medical instruments and equipment. Its ability to function at low temperatures makes it particularly suitable for heat-sensitive materials, which are commonly used in surgical tools, implants, and diagnostic devices. Additionally, the increasing emphasis on reducing hospital-acquired infections is encouraging healthcare providers to adopt more reliable and rapid sterilization methods like cold plasma. This trend is further accelerated by the rising demand for minimally invasive procedures and the need for sterile environments in pharmaceutical manufacturing and biotechnology sectors.

For instance, in May 2025, Sterigenics, a Sotera Health company and global leader in outsourced terminal sterilization services, announced the expansion of its Haw River, North Carolina campus with a new X-ray sterilization facility set to open later in the year. Located near Research Triangle Park and BioPharma Crescent, the site will complement the company’s existing gamma facility and provide added capacity for medical device, pharmaceutical, biopharmaceutical, and commercial customers in the Southeast United States. With advanced technology designed for safety, high-throughput processing, and flexibility, the new facility strengthens Sterigenics’ global sterilization network, which already spans 48 locations worldwide.

Cold Plasma Market Opportunity - Expanding Applications in Dermatology and Cosmetic Medicine

One of the most promising opportunities driving the growth of the global cold plasma market is the expanding application of cold plasma technology in dermatology and cosmetic medicine. Cold plasma, characterized by its non-thermal ionized gas properties, offers significant advantages for skin treatment due to its ability to promote wound healing, antimicrobial effects, and tissue regeneration without damaging surrounding healthy tissues. This unique capability has encouraged its adoption in treating various dermatological conditions such as acne, eczema, psoriasis, and chronic wounds. Additionally, cosmetic procedures including skin rejuvenation, scar reduction, and hair restoration are increasingly leveraging cold plasma technology to provide minimally invasive alternatives to traditional treatments.

For instance, in August 2025, Perricone MD, a dermatologist-founded skincare brand known for its science-backed formulas, launched Cold Plasma Plus+ Advanced Hydrating Complex, a next-generation moisturizer powered by patented MICROSPERSE technology, Copper Tripeptide and a Hydra-Osmolyte blend, clinically shown to improve skin tone, texture and hydration within four weeks.

Analyst Opinion (Expert Opinion)

• The cold plasma market is steadily gaining momentum as advancements in medical technology, electronics, and food safety drive adoption. In healthcare, rising demand for non-invasive wound care solutions, skin treatments, and sterilization methods is accelerating growth, supported by favorable regulatory approvals in Europe and North America. At the same time, industries such as semiconductors and packaging are leveraging cold plasma for precision surface modification and eco-friendly sterilization, highlighting its versatility. Opportunities are opening up in personalized medical devices, point-of-care solutions, and sustainable food processing, though high equipment costs and limited awareness among end-users remain notable hurdles. Over the past few years, global conferences like the International Conference on Plasma Medicine, the European Society for Plasma Medicine Congress, and the IEEE International Conference on Plasma Science have played a crucial role in showcasing emerging technologies, encouraging collaborations between researchers and companies, and shaping regulatory and academic discussions that influence long-term market direction.
• Recent initiatives underscore how quickly cold plasma is moving from the lab to real-world impact. For instance, Plasmacure in the Netherlands has advanced its PLASOMA wound healing system through EU-backed projects, while German firm neoplas med secured MDR certification for its plasmajet device, reinforcing regulatory confidence in medical applications. In respiratory care, Viromed Medical AG is working with the BREATH network in Hannover to explore cold plasma as a “digital antibiotic” for pneumonia prevention. Such projects, along with Horizon 2020 funding support and pilot studies across Europe, are bridging gaps between research, clinical validation, and commercial deployment, making cold plasma an increasingly relevant technology in both healthcare and industrial sectors.

Market Segmentation

• Regime Insights (Revenue, USD Bn, 2020 - 2032)
  • Atmospheric Pressure Cold Plasma
  • Low-Pressure Cold Plasma
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Wound Healing and Tissue Regeneration
  • Cancer Treatment and Oncology Applications
  • Dentistry (tooth whitening, sterilization, biofilm removal)
  • Dermatology (skin infections, cosmetic applications)
  • Blood Coagulation and Hemostasis
  • Infection Control and Sterilization (surgical instruments, hospital surfaces)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Clinics
  • Dental Clinics
  • Diagnostic and Research Laboratories
  • Ambulatory Surgical Centers
  • Specialized Dermatology and Oncology Centers
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Adtec Healthcare Limited
  • CINOGY System GmbH
  • terraplasma medical GmbH
  • neoplas med GmbH
  • Plasmacure B.V.
  • Relyon Plasma GmbH (TDK Electronics subsidiary)
  • US Medical Innovations, LLC
  • Apyx Medical Corporation
  • Alma Lasers (Sisram Medical)
  • Bovie Medical (Apyx Medical)
  • Eneka Medical
  • Medispec Ltd.
  • Energenesis Biomedical Co., Ltd.
  • Nutech Medical Devices
  • INNOVO Plasma Technologies

Sources

Primary Research Interviews

Industry Stakeholders List

• Senior executives from cold plasma device manufacturers
• Product development managers in MedTech companies
• Regulatory affairs experts in medical technology firms
• Operations heads at electronics manufacturing units
• Business development directors in food processing companies
• Hospital procurement managers

End-users List

• Dermatologists and wound care specialists
• Clinical researchers in plasma medicine
• Engineers in semiconductor fabrication plants
• Food safety officers in processing facilities
• Infection control specialists in hospitals
• Patients using cold plasma devices for chronic wounds

Government and International Databases

• World Health Organization (WHO)
• European Medicines Agency (EMA)
• U.S. Food and Drug Administration (FDA)
• National Institutes of Health (NIH)
• European Commission Horizon 2020 Project Database
• Organisation for Economic Co-operation and Development (OECD)

Trade Publications

• Medical Device and Diagnostic Industry (MD+DI)
• Food Quality & Safety Magazine
• Semiconductor Digest
• European Medical Journal (EMJ) Innovations
• Biophotonics International
• Packaging World

Academic Journals

• Plasma Medicine (IOS Press)
• Journal of Physics D: Applied Physics
• Nature Scientific Reports
• Journal of Clinical Plasma Medicine
• IEEE Transactions on Plasma Science
• Journal of Applied Physics

Reputable Newspapers

• The New York Times – Science & Health
• The Guardian – Health & Technology
• The Wall Street Journal – HealthCare & Tech
• Financial Times – Global Technology
• Suddeutsche Zeitung (Germany) – Science Section
• The Hindu – Science & Technology

Industry Associations

• European Society for Plasma Medicine (ESPM)
• International Plasma Chemistry Society (IPCS)
• American Vacuum Society (AVS)
• International Society for Plasma Medicine (ISPM)
• Institute of Electrical and Electronics Engineers (IEEE) Plasma Science and Applications Committee
• European Society for Biomaterials (ESB)

Public Domain Resources

• U.S. National Library of Medicine
• ResearchGate Open Access Articles
• European Open Science Cloud (EOSC)
• Zenodo (EU-funded open science repository)
• National Center for Biotechnology Information (NCBI)

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years